598
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of selective-serotonin reuptake inhibitors and anti-androgens to manage sexual compulsivity in individuals serving a custodial sentence for a sexual offence

ORCID Icon, , , , , , , , ORCID Icon, , & show all
Pages 425-460 | Received 19 Dec 2022, Accepted 07 Feb 2024, Published online: 16 Apr 2024

Figures & data

Table 1. Mean and median scores for age, IQ, RM2000 (sexual), RM2000 (violent) and SARN across experimental and comparison samples.

Table 2. Descriptive statistics for clinical measures and correlation with Sexual Compulsivity.

Figure 1. Mean sexual compulsivity scores for participants taking (i) Anti-Androgens (n = 8), (ii) Selective-serotonin reuptake inhibitors (n = 69) and (iii) no medication (n = 58) pre-medication and three months post-medication.

Figure 1. Mean sexual compulsivity scores for participants taking (i) Anti-Androgens (n = 8), (ii) Selective-serotonin reuptake inhibitors (n = 69) and (iii) no medication (n = 58) pre-medication and three months post-medication.

Figure 2. Frequencies of participants below and above cut offs (1.5 and >2.1) for sexual compulsivity pre-medication and (three months) post-medication for (i) Anti-Androgens (n = 8), (ii) Selective-Serotonin Reuptake Inhibitors (n = 72) and (iii) no medication (n = 58) pre-medication and three months post-medication.

Figure 2. Frequencies of participants below and above cut offs (≥1.5 and >2.1) for sexual compulsivity pre-medication and (three months) post-medication for (i) Anti-Androgens (n = 8), (ii) Selective-Serotonin Reuptake Inhibitors (n = 72) and (iii) no medication (n = 58) pre-medication and three months post-medication.